| abstract |
The present disclosure relates to compositions, methods, and uses utilizing isolated anti-FcRn antibodies or antigen-binding fragments thereof for preventing, modulating or treating warm autoimmune hemolytic anemia by binding to neonatal Fc receptor (FcRn). |